Navigation Links
Investigational Studies Highlight Potential Utility of Zevalin(R) (Ibritumomab Tiuxetan) Radioimmunotherapy in Stem Cell Transplantation for Non-Hodgkin's Lymphoma
Date:6/1/2008

. Except as may be required by law, CTI does not intend to update or alter its forward-looking statements whether as a result of new information, future events, or otherwise.

Media Contact:

Dan Eramian

T: 206.272.4343

C: 206.854.1200

Lindsey Jesch

T: 206.272.4347

E: media@ctiseattle.com

http://www.CellTherapeutics.com/media.htm

Investors Contact:

Leah Grant

T: 206.282.7100

F: 206.272.4434

E: invest@ctiseattle.com

http://www.CellTherapeutics.com/investors.htm

Medical Information Contact:

T: 800.715.0944

E: info@askarm.com

T 206.282.7100

F 206.272.4010


'/>"/>
SOURCE Cell Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Lexicon Presents Class of Compounds Modulating TPH1, the Target for its LX1031 Investigational Drug for Irritable Bowel Syndrome
2. FDA Grants Orphan Drug Designation to TREANDA, an Investigational Treatment for Chronic Lymphocytic Leukemia
3. Sanofi Pasteurs Investigational H5N1 Influenza Vaccine Achieves High Immune Response at low Dosage
4. Survival Data Presented From Phase II Study of Investigational Drug ZD4054 in Hormone-Resistant Prostate Cancer Patients
5. UCB Announces New Data Showing Investigational Drug Lacosamide Significantly Reduced Seizures in Refractory Epilepsy Patients
6. Lexicon Files Investigational New Drug Application for LX1032 as a Potential Treatment for Carcinoid Syndrome
7. New Drug Application for Tolvaptan, Otsukas Investigational Novel Oral Treatment for Worsening Heart Failure and Hyponatremia, Accepted by the U.S. Food and Drug Administration
8. Daiichi Sankyo, Lilly Submit New Drug Application for Investigational Antiplatelet Drug, Prasugrel, with U.S. Food and Drug Administration
9. Velcura Therapeutics, Inc. Can Begin Clinical Trials Following Successful Investigational New Drug Application to U.S. FDA
10. CHOP-Zevalin(R) Investigational Regimen Produces 95% Complete Remission and 75% Estimated Two Year Progression-Free Survival in Elderly Patients with Diffuse Large B-cell Lymphoma
11. AstraZeneca Completes Enrollment in Two Pivotal Phase III Studies of the Investigational Drug Vandetanib (ZACTIMA(R)) in Non-Small Cell Lung Cancer (NSCLC)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... November 24, 2014 The new ... from METTLER TOLEDO demonstrates how to reduce the ... analytics and sample panel design can be complicated, ... and protect against corrosion and deposition. Dedicated single ... significant amount of panel space. Additionally, installing and ...
(Date:11/24/2014)... November 24, 2014 Senior Vice ... for dynamic leadership skills, business acumen ... medical information products and services, congratulates Diane Bartoli ... Reference and Workflow, Elsevier Clinical Solutions, for being recognized ... ® Awards issue of Profiles in Diversity ...
(Date:11/22/2014)... 2014 Two new educational webinars hosted by ... for ALS research and how the pharmaceutical industry can make ... Bucket Challenge: Where Does the ALS Money Go? , Featuring ... 2014, Time: 1:30pm ET, Register to attend , ... Merit Cudkowicz, Julianne Dorn Professor of Neurology at Massachusetts General ...
(Date:11/22/2014)... November 21, 2014 Prominent academics, ... will gather on December 3rd at Genetic Rx, ... series. GeneticRx will take place at the Joseph ... and will discuss the present and future of ... skipping, and gene editing—as well as the treatment ...
Breaking Biology Technology:New Video Shows How to Simplify Cycle Chemistry Sample Panels to Save Time and Costs 2Elsevier Clinical Solutions' Diane Bartoli Featured In Profiles in Diversity Journal's 13th Annual Women Worth Watching Issue 2Elsevier Clinical Solutions' Diane Bartoli Featured In Profiles in Diversity Journal's 13th Annual Women Worth Watching Issue 3DrugDev Webinars in December to Explore What Comes Next for ALS Research and How We Can Make Life Easier for Clinical Sites 2Pioneering Academics and Key Industry Leaders to Discuss Rare Diseases and the Emergence of New Genetic Medicines at Genetic Rx on December 3rd 2
... Assembly Speaker Mike Huebsch , R-West Salem, and ... legislators to serve on the Speaker's Task Force on Information ... exploring a number of failed information technology projects in state ... private sectors. , ,In addition to Montgomery, who will serve ...
... year's Biotechnology Industry Organization convention in Chicago, it wasn't ... While Chicago is a business leader in almost every ... its biotech. Pharmaceutical companies, yes; biotech firms, not really. ... so hopped up on biotech research, investors, and boom-time ...
... of healthcare information technology continues its slow but steady march, new ... progress that has been made, and the issues still to address, ... set for May 9 and 10 at the Fluno Center ... Dr. Barry Chaiken Dr. Barry Chaiken, associate chief medical ...
Cached Biology Technology:Eight lawmakers named to Speaker's IT task force 2Getting noticed in Genetown: Wisconsin biotech on display 2Getting noticed in Genetown: Wisconsin biotech on display 3Getting noticed in Genetown: Wisconsin biotech on display 4Digital Healthcare Conference 2007: Mounting obstacles for health IT 2Digital Healthcare Conference 2007: Mounting obstacles for health IT 3
(Date:11/5/2014)... the UTSA College of Sciences, is one of ... a two-year $300,00 National Science Foundation (NSF) Early ... supports President Obama,s BRAIN Initiative, a federal effort ... will demystify complex brain processes. , According ... into the interactions of multiple components, each working ...
(Date:11/4/2014)... Medicine announced today that it is a Grand ... Bill & Melinda Gates Foundation. Laura Goetzl, ... Sciences; and Vice Chair of Research and Academic ... pursue an innovative global health and development research ... Neurodevelopment.", Grand Challenges Explorations (GCE) funds individuals worldwide ...
(Date:11/4/2014)... Nov. 4, 2014   Neurotechnology , a ... that the latest version of its fingerprint matching ... Ongoing MINEX evaluation organized by NIST. The ... using the INCITS 378 fingerprint standard template format. ... public tenders in the United States ...
Breaking Biology News(10 mins):UTSA biology professor awarded $300,000 NSF grant for brain research 2UTSA biology professor awarded $300,000 NSF grant for brain research 3Temple University School of Medicine receives Grand Challenges Explorations grant 2Neurotechnology Places Second in Ongoing MINEX Ranking for Fingerprint Matching Algorithms 2Neurotechnology Places Second in Ongoing MINEX Ranking for Fingerprint Matching Algorithms 3
... American Psychiatric Association today released the proposed draft diagnostic ... Manual of Mental Disorders (DSM). The draft ... is the standard classification of mental disorders used by ... for diagnostic and research purposes. "These draft ...
... plants stave off attacks by Hessian fly larvae by essentially ... according to a study by Purdue University and the U.S. ... to human intestines - were observed in three different feeding ... that were given nothing to eat showed no damage to ...
... AMES, Iowa -- A previous six-month study by Iowa ... of soy protein, rich in isoflavones, lessened lumbar spine ... expanded three-year study by some of those same researchers ... who ingested soy isoflavone tablets, except for a modest ...
Cached Biology News:APA announces draft diagnostic criteria for DSM-5 2APA announces draft diagnostic criteria for DSM-5 3APA announces draft diagnostic criteria for DSM-5 4APA announces draft diagnostic criteria for DSM-5 5Resistant wheat goes for the gut to protect against Hessian flies 2Multicenter study finds little effect of soy isoflavones on bone loss in postmenopausal women 2Multicenter study finds little effect of soy isoflavones on bone loss in postmenopausal women 3